Korea Cardiovascular Stent Research Institute, Heart Center of Chonnam National University Hospital, Gwangju, Republic of Korea.
Int J Cardiol. 2013 Feb 10;163(1):1-4. doi: 10.1016/j.ijcard.2012.02.003. Epub 2012 Feb 25.
There are controversies about the use of drug-eluting stent (DES) in patients with acute myocardial infarction (AMI). Recent trials of DES in patients with AMI have shown the relative safety of DES. However, some physicians hesitate to use DES in AMI patients because of increased risk of stent thrombosis and death. We summarized in this article about the efficacy and safety of DES in AMI patients who were enrolled in Korea Acute Myocardial Infarction Registry (KAMIR).
关于急性心肌梗死（AMI）患者使用药物洗脱支架（DES）存在争议。最近 DES 在 AMI 患者中的临床试验表明 DES 相对安全。然而，一些医生因为担心支架血栓形成和死亡风险增加而对 AMI 患者使用 DES 犹豫不决。我们总结了在韩国急性心肌梗死注册研究（KAMIR）中接受 DES 治疗的 AMI 患者的疗效和安全性。
